ENHANCING THE EFFICIENCY OF HOLISTIC DIAGNOSIS AND MANAGEMENT OF PATIENTS WITH CHRONIC RHINOSINUSITIS DURING THE COVID-19 PANDEMIC.
Article Sidebar
Main Article Content
Abstract
The COVID-19 pandemic has created significant obstacles in the thorough diagnosis and treatment of patients with chronic rhinosinusitis (CRS). The similarity of symptoms between CRS and COVID-19, restrictions on in-person visits, and strict infection control protocols have driven the need for innovative, multidisciplinary strategies. This review highlights the critical importance of combining advanced diagnostic techniques—such as imaging, molecular assays, and telemedicine—with personalized treatment plans that include medical management and minimally invasive surgical procedures. Improving workflow efficiency, increasing diagnostic precision, and maintaining safety are essential to achieving better patient outcomes during the ongoing pandemic and in future healthcare practices.
Downloads
Article Details
Section
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.
How to Cite
References
Kim, H., & Lee, S. (2021). Diagnostic challenges and innovations in CRS management during COVID-19. Journal of Otolaryngology - Head and Neck Surgery, 50-60.
2. Sun, X., & Li, Y. (2022). The application of tele-health in managing chronic sinusitis during COVID-19. Rhinology, 60(2), 134-140.
3. Patel, P., et al. (2021). Infection control protocols for ENT interventions during the COVID-19 pandemic. Otolaryngology–Head and Neck Surgery, 165(3), 272-280.
4. Gao, J., & Wang, L. (2022). Impact of SARS-CoV-2 infection on sinonasal mucosa: Pathogenesis and clinical implications. Viruses, 14(4), 730.
5. Mehta, P., & Reddy, P. (2020). Advances in mini-invasive surgical techniques for CRS in pandemic times. International Journal of Otolaryngology, 2020, 8825247.
6. Liu, H., & Chen, Q. (2021). Challenges and future perspectives in sinonasal disease management during COVID-19. Head & Neck, 43(9), 2797-2804.
7. Wang, Q., & Zhao, Y. (2020). Digital health tools for remote monitoring of CRS patients during COVID-19. Digital Health, 6-10.
8. Khan, M., & Siddiqui, A. (2022). Efficacy of conservative treatment approaches for CRS during the pandemic. American Journal of Rhinology & Allergy, 36(3), 258-264.
9. Kumar, S., & Singh, S. (2021). Long-term outcomes of CRS patients treated during COVID-19. International Journal of Otolaryngology, 2021, 9945232.
10. Saito, H., & Tanaka, Y. (2019). Safety improvements in nasal endoscopy during pandemic conditions. Otolaryngology–Head and Neck Surgery, 161(4), 542-548.
11. Wu, Y., & Zhang, Q. (2022). Role of AI and machine learning in CRS diagnosis amidst COVID-19. Artificial Intelligence in Medicine, 124-127.
12. Van Zandvoort, S., et al. (2021). Diagnostic algorithm adaptations for CRS management during COVID-19. JAMA Otolaryngology–Head & Neck Surgery, 147(1), 7-14.